Donate monthly. Set up a standing order online

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

Group B streptococcal surface proteins: role in pathogenesis and evaluation as vaccine components

  • Researchers:
    Professor Gunnar Lindahl
  • Start Date:
    01 January 2002
  • Category:
    Prevention
  • Location:
    Lund University, Lund, Sweden

The group B streptococcus (GBS) is the leading cause of septicaemia and meningitis in newborns. We are studying two GBS surface proteins, Rib and alpha, which elicit protective immunity and are members of the same protein family. About 90% of all GBS strains express Rib or alpha, and a combination of these proteins works well as a vaccine in a mouse model. It would be an advantage if a single protein could be used. Different chimeric proteins, derived from Rib and alpha, will therefore be constructed and analyzed for ability to elicit protective immunity.

The role of Rib and alpha in pathogenesis is unknown. The function of Rib may be of particular interest, because Rib is expressed by all GBS strains of serotype III, which cause most cases of meningitis. Our hypothesis is that Rib promotes binding to epithelial or endothelial cells. If Rib indeed can be shown to act as an adhesin, attempts will be made to identify the corresponding human receptor. The results may provide information of general interest with regard to meningitis.

It is unknown why certain children contract GBS disease. Possibly, these children are poorly protected, because of low levels of maternal antibodies to GBS surface structures. We have initiated a study, aimed at analyzing the level of antibodies to GBS proteins in newborns with GBS disease. If these children, and their mothers, have low antibody levels, it might become possible to identify a risk group among pregnant women, and prevention of disease in the child.

Results from this study have been published in scientific journals as follows:

Larsson C, Holmgren J, Lindahl G, Bergquist C.
Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
Infect Immun 2004 Feb;72(2):1184-7.
http://iai.asm.org/cgi/reprint/72/2/1184.pdf

Lindahl G, Stalhammar-Carlemalm M, Areschoug T.
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.
Clin Microbiol Rev 2005 Jan;18(1):102-27.
http://cmr.asm.org/cgi/reprint/18/1/102.pdf

Waldemarsson J, Areschoug T, Lindahl G, Johnsson E,
The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures.
J Bacteriol 2006 Jan;188(2):378-88.
http://jb.asm.org/cgi/reprint/188/2/378.pdf

Larsson C, Lindroth M, Nordin P, Stalhammar-Carlemalm M, Lindahl G, Krantz I.
Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
Arch Dis Child Fetal Neonatal Ed 2006 Nov;91(6):F403-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=PubMed
Emma Faye Wallgren
Group B Strep meningitis
Group B Strep meningitis at one month and one day

We would never have ourselves or our children kept alive by machines.

More stories
Search research projects
Meet us on Facebook